Company Respirerx Pharmaceuticals Inc Other OTC
Equities
US2205243007
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 13-03-21 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 13-03-21 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 14-10-14 |
David Dickason
PRN | Corporate Officer/Principal | - | 20-09-14 |
Marc M. Radin
AUD | Comptroller/Controller/Auditor | - | 13-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 13-03-21 |
Director/Board Member | - | 23-03-21 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 13-03-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 365,418,647 | 341,184,734 ( 93.37 %) | 0 | 93.37 % |
Stock B | 0 | 37,500 | 0 | 0 |
Company contact information
RespireRx Pharmaceuticals, Inc.
126 Valley Road Suite C
07452, Glen Rock
+201 444 4947
http://www.respirerx.com![address Respirerx Pharmaceuticals Inc](https://cdn.zonebourse.com/static/address/5787161.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.38% | 127B | |
+24.61% | 117B | |
+25.44% | 27.67B | |
-17.93% | 20.33B | |
-15.17% | 16.79B | |
-15.01% | 15.63B | |
+12.68% | 14.84B | |
-47.10% | 14.65B | |
+56.49% | 14.43B |
- Stock Market
- Equities
- RSPI Stock
- Stock
- Company Respirerx Pharmaceuticals Inc